سرطان البنكرياس

طلب موعد

Survival rates

A survival rate is a statistic based on groups of people with the same type of cancer. A five-year relative survival rate estimates the percentage of people expected to survive the effects of their cancer for at least five years while accounting for deaths from other causes.

For people diagnosed with pancreatic cancer between 2016 and 2022, the overall five-year relative survival rate was 13.7%.

Survival statistics

Survival varies greatly depending on how far pancreatic cancer has spread when it is diagnosed. Survival statistics often group pancreatic cancer as localized, regional or distant. These categories are different from stages 0 through 4 and do not match them exactly.

  • Localized pancreatic cancer. The cancer hasn't spread beyond the pancreas. The five-year relative survival rate is 43.6%.
  • Regional pancreatic cancer. The cancer has spread to nearby tissues or lymph nodes. The five-year relative survival rate is 17.0%.
  • Distant pancreatic cancer. The cancer has spread, also called metastasized, to distant parts of the body. The five-year relative survival rate is 3.4%.

Pancreatic cancer is difficult to treat in part because it often isn't found until it is advanced. Surgery is the only potential cure, but only some pancreatic cancers can be removed with surgery.

What affects prognosis?

The stage of pancreatic cancer is one of the most important factors affecting prognosis, which is the expected course of the cancer. In people who have surgery, prognosis also can be affected by whether cancer is found in nearby lymph nodes and whether the surgeon was able to remove all of the cancer. Other tumor characteristics and levels of the tumor marker CA 19-9 also may provide information about prognosis.

These factors are one reason survival statistics can't predict exactly how long one person will live. Your healthcare team can consider information about your cancer and treatment when discussing what survival statistics may mean for you.

What you can do

Survival statistics describe what happened in large groups of people, but they can't predict exactly what will happen to one person. Treatment and the cancer's response to treatment can vary greatly.

Ask your healthcare team what the available survival statistics may mean for your situation. Your care team can consider the cancer's stage, treatment options and other individual factors when discussing your outlook.

طلب تحديد موعد
التشخيص والعلاج
04/05/2024

Living with سرطان البنكرياس?

Connect with others like you for support and answers to your questions in the Pancreatic Cancer support group on Mayo Clinic Connect, a patient community.

Pancreatic Cancer Discussions

Colleen Young, Connect Director
Have you ever had hiccups with or after chemotherapy?

134 Replies Sat, Sep 26, 2026

Teresa, Volunteer Mentor
How do I eat after digestive tract surgery?

235 Replies Tue, Sep 22, 2026

Colleen Young, Connect Director
Pancreatic Cancer Group: Introduce yourself and connect with others

2409 Replies Mon, Sep 21, 2026

See more discussions
  1. AskMayoExpert. Pancreatic cancer (adult). Mayo Clinic; 2022.
  2. Groggins M, et al. Management of patients with increased risk for familial pancreatic cancer: Updated recommendations from the International Cancer of the Pancrease Screening (CAPS) Consortium. Gut. 2020; doi:10.1136/gutjnl- 2019- 319352.
  3. Debouk M, et al. The Multicenter Cancer of Pancreas screening study: Impact on stage and survival. Journal of Clinical Oncology. 2022; doi:10.1200/JCO.22.00298.
  4. Pancreatic adenocarcinoma. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455. Accessed April 27, 2023.
  5. De la Fuente J, et al. How I approach screening for pancreatic cancer. American Journal of Gastroenterology. 2021; doi:10.14309/ajg.0000000000001305.
  6. Fernandez-del Castillo C. Clinical manifestations, diagnosis and staging of exocrine pancreatic cancer. https://www.uptodate.com/contents/search. Accessed April 26, 2023.
  7. Pancreatic cancer treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/pancreatic/hp/pancreatic-treatment-pdq. Accessed April 26, 2023.
  8. Distress management. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1455 Accessed April 27, 2023.
  9. Ryan DP. Initial systemic chemotherapy for metastatic exocrine pancreatic cancer. https://www.uptodate.com/contents/search. Accessed April 26, 2023.
  10. AskMayoExpert. Pancreas ductal adenocarcinoma: Diagnosis and treatment (adult). Mayo Clinic; 2022.
  11. Fernandez-del Castillo C, et al. Overview of surgery in the treatment of exocrine pancreatic cancer and prognosis. https://www.uptodate.com/contents/search. Accessed April 26, 2023.
  12. NPF Centers of Excellence. National Pancreas Foundation. https://pancreasfoundation.org/patient-resources/npf-centers-of-excellence/. Accessed April 27, 2023.
  13. Niederhuber JE, et al., eds. Carcinoma of the pancreas. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. http://www.clinicalkey.com. Accessed April 28, 2023.
  14. Sugumar A, et al. Distinguishing pancreatic cancer from autoimmune pancreatitis. Current Gastroenterology Reports. 2010;12:91.
  15. Ami T. Allscripts EPSi. Mayo Clinic. Feb. 28, 2022.
  16. Pancreatic Cancer Genetic Epidemiology (PACGENE) Study. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00526578. Accessed April 26, 2023.
  17. Thind K et al. Immunotherapy in pancreatic cancer treatment: A new frontier. Therapeutic Advances in Gastroenterology. 2017;10:168.
  18. Tee MC, et al. Laparoscopic pancreaticoduodenectomy: Is it an effective procedure for pancreatic ductal adenocarcinoma? Advances in Surgery. 2015;49:143.
  19. Merrell KW, et al. Predictors of locoregional failure and impact on overall survival in patients with resected exocrine pancreatic cancer. International Journal of Radiation Oncology. 2016;doi:10.1016/j.ijrobp.2015.11.003.
  20. Moris M, et al. Risk factors for malignant progression of intraductal papillary mucinous neoplasms. Digestive and Liver Disease. 2015;47:495.
  21. Pancreatic cancer: Symptoms and signs. Cancer.Net. https://www.cancer.net/cancer-types/pancreatic-cancer/symtpms-and-signs. Accessed May 2, 2023.
  22. Loncle C, et al. The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes KRAS-G12D-mediated pancreatic cancer initiation. Cell Death and Disease. 2016;7:32295.
  23. Thiels CA, et al. Outcomes of pancreaticoduodenectomy for pancreatic neuroendocrine tumors: Are combined procedures justified? Journal of Gastrointestinal Surgery. 2016;20:891.

سرطان البنكرياس